Cooper Companies (COO) | Financial Analysis & Statements
The Cooper Companies Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
1.0B
Gross Profit
695.2M
67.88%
Operating Income
212.8M
20.78%
Net Income
130.8M
12.77%
EPS (Diluted)
$0.66
Balance Sheet Metrics
Total Assets
12.4B
Total Liabilities
4.2B
Shareholders Equity
8.2B
Debt to Equity
0.50
Cash Flow Metrics
Operating Cash Flow
125.2M
Free Cash Flow
149.9M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2025
Cooper Companies Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.1B | 3.9B | 3.6B | 3.3B | 2.9B |
| Cost of Goods Sold | 1.4B | 1.3B | 1.2B | 1.2B | 966.7M |
| Gross Profit | 2.7B | 2.6B | 2.4B | 2.1B | 2.0B |
| Gross Margin % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Operating Expenses | |||||
| Research & Development | 172.2M | 155.1M | 137.4M | 110.3M | 92.7M |
| Selling, General & Administrative | 1.6B | 1.5B | 1.5B | 1.3B | 1.2B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.8B | 1.7B | 1.6B | 1.5B | 1.3B |
| Operating Income | 682.9M | 705.7M | 533.1M | 507.6M | 505.8M |
| Operating Margin % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 100.0M | 114.3M | 105.3M | 57.3M | 23.1M |
| Other Non-Operating Income | -16.4M | -9.1M | -14.9M | 25.0M | 8.8M |
| Pre-tax Income | 566.5M | 582.3M | 412.9M | 475.3M | 491.5M |
| Income Tax | 191.6M | 190.0M | 118.7M | 89.5M | -2.5B |
| Effective Tax Rate % | 33.8% | 32.6% | 28.7% | 18.8% | -499.1% |
| Net Income | 374.9M | 392.3M | 294.2M | 385.8M | 2.9B |
| Net Margin % | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% |
| Key Metrics | |||||
| EBITDA | 1.1B | 1.1B | 892.9M | 878.7M | 823.9M |
| EPS (Basic) | $1.91 | $1.97 | $1.49 | $1.95 | $14.93 |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $14.79 |
| Basic Shares Outstanding | 195900000 | 199600000 | 197900000 | 197400000 | 197200000 |
| Diluted Shares Outstanding | 195900000 | 199600000 | 197900000 | 197400000 | 197200000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Cooper Companies Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 110.6M | 107.6M | 120.8M | 138.2M | 95.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 829.0M | 717.0M | 609.7M | 557.8M | 515.3M |
| Inventory | 846.0M | 802.7M | 735.6M | 628.7M | 585.6M |
| Other Current Assets | 320.8M | 324.2M | 238.8M | 208.9M | 179.3M |
| Total Current Assets | 2.1B | 2.0B | 1.7B | 1.5B | 1.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.1M | 2.9M | 3.8M | 19.2M | 257.0M |
| Goodwill | 9.3B | 9.5B | 9.0B | 9.1B | 6.4B |
| Intangible Assets | 1.6B | 1.8B | 1.7B | 1.9B | 1.3B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 2.8B | 2.9B | 3.0B | 3.0B | 2.9B |
| Total Non-Current Assets | 10.3B | 10.4B | 10.0B | 10.0B | 8.1B |
| Total Assets | 12.4B | 12.3B | 11.7B | 11.5B | 9.6B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 300.4M | 260.5M | 261.9M | 248.8M | 161.4M |
| Short-term Debt | 47.8M | 33.3M | 45.4M | 412.6M | 83.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 426.1M | 424.3M | 363.3M | 373.1M | 319.6M |
| Total Current Liabilities | 1.1B | 1.0B | 969.0M | 1.3B | 732.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.5B | 2.6B | 2.5B | 2.4B | 1.4B |
| Deferred Tax Liabilities | 93.3M | 96.0M | 101.5M | 149.9M | 24.1M |
| Other Non-Current Liabilities | 282.8M | 311.6M | 239.2M | 225.2M | - |
| Total Non-Current Liabilities | 3.0B | 3.2B | 3.1B | 3.0B | 1.9B |
| Total Liabilities | 4.2B | 4.2B | 4.1B | 4.3B | 2.7B |
| Equity | |||||
| Common Stock | 21.8M | 21.7M | 21.6M | 5.4M | 5.4M |
| Retained Earnings | 7.6B | 7.3B | 6.9B | 6.6B | 6.2B |
| Treasury Stock | 995.2M | 706.0M | 710.3M | 714.5M | 639.6M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 8.2B | 8.1B | 7.6B | 7.2B | 6.9B |
| Key Metrics | |||||
| Total Debt | 2.5B | 2.6B | 2.6B | 2.8B | 1.5B |
| Working Capital | 993.6M | 928.7M | 735.9M | 253.4M | 733.2M |
Balance Sheet Composition
Cooper Companies Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 374.9M | 392.3M | 294.2M | 385.8M | 2.9B |
| Depreciation & Amortization | 377.4M | 375.1M | 367.7M | 346.1M | 309.3M |
| Stock-Based Compensation | 70.5M | 75.1M | 62.1M | 54.2M | 43.8M |
| Working Capital Changes | -261.0M | -321.9M | -290.1M | -179.0M | -219.0M |
| Operating Cash Flow | 742.6M | 678.2M | 486.8M | 682.9M | 674.5M |
| Investing Activities | |||||
| Capital Expenditures | -362.4M | -421.2M | -392.5M | -242.0M | -214.4M |
| Acquisitions | -10.5M | -343.4M | -56.5M | -1.6B | -235.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -372.9M | -764.6M | -449.0M | -1.8B | -450.3M |
| Financing Activities | |||||
| Share Repurchases | -290.1M | 0 | 0 | -78.5M | -24.8M |
| Dividends Paid | 0 | 0 | -3.0M | -3.0M | -3.0M |
| Debt Issuance | 3.1B | 3.5B | 2.1B | 1.5B | 1.4B |
| Debt Repayment | -3.2B | -3.5B | -2.0B | -561.5M | -1.4B |
| Financing Cash Flow | -417.1M | 5.6M | -183.8M | 1.2B | -337.8M |
| Free Cash Flow | 433.7M | 288.1M | 215.0M | 450.4M | 524.2M |
| Net Change in Cash | -47.4M | -80.8M | -146.0M | 46.1M | -113.6M |
Cash Flow Trend
Cooper Companies Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
33.48
Forward P/E
13.41
Price to Book
1.57
Price to Sales
3.16
PEG Ratio
1.18
Profitability Ratios
Profit Margin
9.67%
Operating Margin
20.78%
Return on Equity
4.87%
Return on Assets
3.64%
Financial Health
Current Ratio
1.34
Debt to Equity
33.20
Beta
1.07
Per Share Data
EPS (TTM)
$2.01
Book Value per Share
$42.87
Revenue per Share
$20.96
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| COO | 12.7B | 33.48 | 1.57 | 4.87% | 9.67% | 33.20 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Alcon | 45.8B | 40.84 | 2.07 | 5.23% | 11.28% | 23.63 |
| ResMed | 32.0B | 21.69 | 5.06 | 25.68% | 27.53% | 13.41 |
| West Pharmaceutical | 22.1B | 40.99 | 6.94 | 19.13% | 16.85% | 10.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.






